18 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Synthesis and antimycobacterial activity of capuramycin analogues. Part 2: acylated derivatives of capuramycin-related compounds.
Sankyo
Identification of novel inhibitors of phospho-MurNAc-pentapeptide translocase MraY from library screening: Isoquinoline alkaloid michellamine B and xanthene dye phloxine B.
University of Warwick
Mechanistic analysis of muraymycin analogues: a guide to the design of MraY inhibitors.
Hokkaido University
Synthesis and Biological Evaluation of Muraymycin Analogues Active against Anti-Drug-Resistant Bacteria.
TBA
Synthesis and biological evaluation of a diazepanone-based library of liposidomycins analogs as MraY inhibitors.
University of Paris
Bacterial transferase MraY inhibitors: synthesis and biological evaluation.
University of Paris
Function-oriented synthesis of simplified caprazamycins: discovery of oxazolidine-containing uridine derivatives as antibacterial agents against drug-resistant bacteria.
Hokkaido University
Synthesis of capuramycin and its analogues via a Ferrier-type I reaction and their biological evaluation.
Hokkaido University
Design, synthesis and conformation-activity relationship analysis of LNA/BNA-type 5'-O-aminoribosyluridine as MraY inhibitors.
Hokkaido University
Synthesis and antimycobacterial activity of capuramycin analogues. Part 1: substitution of the azepan-2-one moiety of capuramycin.
Sankyo
Synthesis and evaluation of cyclopentane-based muraymycin analogs targeting MraY.
Duke University
Synthesis of analogues of the O-beta-D-ribofuranosyl nucleoside moiety of liposidomycins. Part 1: contribution of the amino group and the uracil moiety upon the inhibition of MraY.
Aventis Pharma
Caprazamycins: Promising lead structures acting on a novel antibacterial target MraY.
Griffith University
Lipophosphonoxins: new modular molecular structures with significant antibacterial properties.
Academy of Sciences of The Czech Republic V.V.I.